Hypericin activates L-type Ca2+ channels in cardiac myocytes

Journal of Natural Products

Volumn 70, Issue 4, 2007, Pages 510-514

  Sauviat, Martin Pierre ^a   Colas, Anthony ^a   Chauveau, Marie Jeanne ^b   Drapier, Jean Claude ^b   Négrerie, Michel ^a  

^a LABORATOIRE D OPTIQUE ET BIOSCIENCES   (France)

^b CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

1H 1,2,4 OXADIAZOLO[4,3 A]QUINOXALIN 1 ONE; CALCIUM CHANNEL L TYPE; CALCIUM ION; GUANYLATE CYCLASE; HYPERICIN; PROPRANOLOL; RINGER SOLUTION; STAUROSPORINE; STRONTIUM; TETRODOTOXIN; TETRYLAMMONIUM; URAPIDIL; YOHIMBINE;

ACTION POTENTIAL; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONDUCTANCE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; FROG; HEART ATRIUM; HEART MUSCLE; HEART MUSCLE CELL; MICROELECTRODE; NONHUMAN; PATCH CLAMP; RECEPTOR BLOCKING;

ACTION POTENTIALS; ANIMALS; CALCIUM CHANNELS, L-TYPE; CYCLIC GMP; DOSE-RESPONSE RELATIONSHIP, DRUG; GUANYLATE CYCLASE; HEART; MOLECULAR STRUCTURE; MYOCYTES, CARDIAC; NITRIC OXIDE SYNTHASE TYPE II; OXADIAZOLES; PERYLENE; PHOSPHOPROTEIN PHOSPHATASE; RANIDAE; RECEPTORS, CYTOPLASMIC AND NUCLEAR;

ANURA;

EID: 34249057456     PISSN: 01633864     EISSN: None     Source Type: Journal    
DOI: 10.1021/np060309h     Document Type: Article

References (21)

1. Cardellina, J. H., II. J. Nat. Prod. 2002, 65, 1073-1084.
2. Colas, A.; Sauviat, M.-P. In Rencontres en Toxinologie: Toxines et Recherches Biomédicales; Goudey-Perriere, F., Bon, C., Puiseux-Dao, S., Sauviat, M.-P., Eds.; Editions Scientifiques et Médicales Elsevier: Paris, 2002; pp 153-166.
3. Thomas, C.; Pardini, R. S. Photochem. Photobiol. 1992, 55, 831-837.
4. Miskovsky, P.; Sureau, F.; Chinsky, L.; Turpin, P. Y. Photochem. Photobiol. 1995, 62, 546-549.
5. Siepmann, M.; Krause, S.; Joraschky, P.; Mück-Weymann, M.; Kirch, W. Br. J. Clin. Pharmacol. 2002, 54, 277-282.
6. Kubin, A.; Alth, G.; Jindra, R.; Jessner, G.; Ebermann, R. Photochem. Photobiol. 1996, 36, 103-108.
7. Chesnais, J.-M.; Sauviat, M.-P.; Vassas, J.-M. J. Physiol. (Paris) 1969, 61, 244.
8. Coraboeuf, E.; Carmeliet, E. Pflügers Arch. 1982, 392, 352-359.
9. Shioya, T.; Matsuda, H.; Noma, A. Pflügers Arch. 1993, 422, 427-435.
10. Sauviat, M.-P.; Garnier, P.; Goudey-Perriere, F.; Perriere, C. Toxicon 1995, 33, 1207-1213.
11. Sauviat, M.-P.; Marquais, M.; Vernoux, J.-P. Toxicon 2002, 40, 1155-1163.
12. Sauviat, M.-P.; Colas, A.; Pages, N. BMC Pharmacol. 2002, 2, 15.
13. Sauviat, M.-P.; Vercauteren, J.; Grimaud, N.; Jugé, M.; Nabil, M.; Petit, J.-Y.; Biard, J.-F. J. Nat. Prod. 2006, 69, 559-562.
14. Rivasseau, C.; Racaud, P.; Deguin, A.; Hennion, M.-C. Anal. Chim. Acta 1999, 394, 243-257.
15. Feelisch, M.; Kubitzek, D.; Werringloer, J. In Methods in Nitric Oxide Research; Feelisch, M.; Stamler, J. S., Eds.; John Wiley & Sons, Ltd: Chichester, UK, 1996; pp 455-478.
16. Negrerie, M.; Bouzhir, L.; Martin, J.-L.; Liebl, U. J. Biol. Chem. 2001, 276, 46815-46821.
17. Chesnais, J.-M.; Coraboeuf, E.; Sauviat, M.-P.; Vassas, J.-M. C. R. Acad. Sci. 1969, 273, 204-207.
18. Dittrich, M.; Jurevicius, J.; Georget, M.; Rochais, F.; Fleischmann, B. K.; Hescheler, J.; Fischmeister, R. J. Physiol. 2001, 534, 109-121.
19. Gallo, M. P.; Malan, D.; Bedendi, I.; Biasin, C.; Alloatti, G.; Levi, R. C. Pflügers Arch. 2001, 441, 621-628.
20. Wang, Y. G.; Rechenmacher, C.; Lipsius, S. L. J. Gen. Physiol. 1998, 11, 113-125.
21. Shen, J. B.; Pappano, A. J. J. Pharmacol. Exp. Ther. 2002, 301, 501-506.